Breast and emerging indications for IORT

The advantages of IORT for early breast cancer treatment

Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM

ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC

Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC

IO-108 shows promising results in the treatment of advanced relapsed or refractory solid tumours

MatchMiner: An open-source AI precision medicine trial matching platform

Indications for the appropriate use of a PET-CT scan for common cancers

Choosing Wisely in neoadjuvant treatment for different cancers in the Philippines

The role of CDK4/6 inhibitors in the treatment of metastatic breast cancer

Current indications and challenges with IORT in the Philippines

A multidisciplinary team approach to cancer care in the Philippines